News + Filings Holdings
All
13F
13D/G
Other
|
|
Empery Asset Management, LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/13/2023 |
SC 13G
| Empery Asset Management, LP reports a 6.1% stake in RedHill Biopharma Ltd. |
| 01/13/2023 |
SC 13G
| Empery Asset Management, LP reports a 5.1% stake in X4 Pharmaceuticals, Inc. |
| 01/13/2023 |
SC 13G
| Empery Asset Management, LP reports a 10% stake in Volcon, Inc. |
| 01/12/2023 |
SC 13G
| Empery Asset Management, LP reports a 9.6% stake in Permex Petroleum Corp. |
| 01/12/2023 |
SC 13G
| Empery Asset Management, LP reports a 10% stake in Kiromic Biopharma, Inc. |
| 03/18/2022 |
SC 13G
| Empery Asset Management, LP reports a 9.6% stake in Direct Digital Holdings, Inc. |
| 01/24/2022 |
SC 13G
| Empery Asset Management, LP reports a 5.3% stake in iSpecimen Inc. |
| 08/20/2021 |
SC 13G
| Empery Asset Management, LP reports a 6.9% stake in EyeGate Pharmaceuticals, Inc. |
| 07/26/2021 |
SC 13G
| Empery Asset Management, LP reports a 6.3% stake in Red Cat Holdings, Inc. |
| 07/06/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/28/2021 |
SC 13G
| Empery Asset Management, LP reports a 8.7% stake in Second Sight Medical Products, Inc. |
| 06/15/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/10/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/08/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/03/2021 |
SC 13G
| Empery Asset Management, LP reports a 6.5% stake in 1847 Goedeker Inc. |
| 05/04/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/09/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/24/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/02/2021 |
SC 13G
| Empery Asset Management, LP reports a 8.9% stake in BriaCell Therapeutics Corp. |
| 02/25/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/23/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/19/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/19/2021 |
SC 13G
| Empery Asset Management, LP reports a 6.8% stake in Phio Pharmaceuticals Corp. |
| 02/18/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/18/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/18/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/17/2021 |
SC 13G
| Empery Asset Management, LP reports a 7.4% stake in Hancock Jaffe Laboratories, Inc. |
| 02/10/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/02/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/25/2021 |
SC 13G
| Empery Asset Management, LP reports a 6.7% stake in Lantern Pharma Inc. |
| 01/21/2021 |
SC 13G
| Empery Asset Management, LP reports a 6.9% stake in Titan Pharmaceuticals, Inc. |
| 01/19/2021 |
SC 13G
| Empery Asset Management, LP reports a 10% stake in Viveve Medical, Inc. |
| 01/14/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/14/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|
|
|